BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18408768)

  • 21. Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.
    Wennemers M; Bussink J; Scheijen B; Nagtegaal ID; van Laarhoven HW; Raleigh JA; Varia MA; Heuvel JJ; Rouschop KM; Sweep FC; Span PN
    Breast Cancer Res; 2011 Aug; 13(4):R82. PubMed ID: 21864376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells.
    Yoshida T; Hashimura M; Mastumoto T; Tazo Y; Inoue H; Kuwata T; Saegusa M
    Lab Invest; 2013 Nov; 93(11):1184-93. PubMed ID: 24042437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
    Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
    Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
    Chen C; Yu Z
    Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
    Veuger SJ; Durkacz BW
    DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac glycosides block cancer growth through HIF-1α- and NF-κB-mediated Plk1.
    Xie CM; Liu XY; Yu S; Cheng CH
    Carcinogenesis; 2013 Aug; 34(8):1870-80. PubMed ID: 23615397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stress.
    Park SH; Kim J; Do KH; Park J; Oh CG; Choi HJ; Song BG; Lee SJ; Kim YS; Moon Y
    J Biol Chem; 2014 Sep; 289(39):27118-27133. PubMed ID: 25122760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
    Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
    Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Karin M; Ben-Neriah Y
    Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia.
    Bowers AJ; Scully S; Boylan JF
    Oncogene; 2003 May; 22(18):2823-35. PubMed ID: 12743605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer.
    Yuan Z; Sanders AJ; Ye L; Jiang WG
    Histol Histopathol; 2010 Oct; 25(10):1331-40. PubMed ID: 20712017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
    Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
    Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
    Bendinelli P; Matteucci E; Maroni P; Desiderio MA
    Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
    Oyesanya RA; Lee ZP; Wu J; Chen J; Song Y; Mukherjee A; Dent P; Kordula T; Zhou H; Fang X
    FASEB J; 2008 Aug; 22(8):2639-51. PubMed ID: 18362203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways.
    Kunz M; Bloss G; Gillitzer R; Gross G; Goebeler M; Rapp UR; Ludwig S
    Biochem J; 2002 Aug; 366(Pt 1):299-306. PubMed ID: 12020348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.
    Örd T; Örd D; Adler P; Vilo J; Örd T
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2492-505. PubMed ID: 26094770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.